Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Amato

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Critical Reviews in Oncology/Hematology|July 10, 2003
Thalidomide therapy for renal cell carcinomaRobert J Amato
Surgical Oncology Clinics of North America|November 21, 2007
Current immunotherapeutic strategies in renal cell carcinomaRobert J Amato
Expert Opinion on Biological Therapy|August 31, 2007
5T4-modified vaccinia ankara: progress in tumor-associated antigen-based immunotherapyRobert J Amato
Clinical Genitourinary Cancer|February 15, 2008
Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapyRobert J Amato
Reviews in Urology|September 21, 2006
Vaccine therapy for renal cell carcinomaRobert J Amato
Expert Opinion on Biological Therapy|August 21, 2007
Heat-shock protein-peptide complex-96 for the treatment of cancerRobert J Amato
Current Oncology Reports|December 6, 2001
Thalidomide: an antineoplastic agentRobert J Amato
Expert Opinion on Biological Therapy|January 22, 2010
5T4-modified vaccinia Ankara: progress in tumor-associated antigen-based immunotherapyRobert J Amato
Expert Review of Vaccines|September 5, 2008
Vaccine therapy for renal cancerRobert J Amato
Clinical Genitourinary Cancer|May 30, 2006
A phase I study of paclitaxel/doxorubicin/ thalidomide in patients with androgen- independent prostate cancerRobert J Amato, Harmeet Sarao
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Critical Reviews in Oncology/Hematology|July 10, 2003
Thalidomide therapy for renal cell carcinomaRobert J Amato
Surgical Oncology Clinics of North America|November 21, 2007
Current immunotherapeutic strategies in renal cell carcinomaRobert J Amato
Expert Opinion on Biological Therapy|August 31, 2007
5T4-modified vaccinia ankara: progress in tumor-associated antigen-based immunotherapyRobert J Amato
Clinical Genitourinary Cancer|February 15, 2008
Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapyRobert J Amato
Reviews in Urology|September 21, 2006
Vaccine therapy for renal cell carcinomaRobert J Amato
Expert Opinion on Biological Therapy|August 21, 2007
Heat-shock protein-peptide complex-96 for the treatment of cancerRobert J Amato
Current Oncology Reports|December 6, 2001
Thalidomide: an antineoplastic agentRobert J Amato
Expert Opinion on Biological Therapy|January 22, 2010
5T4-modified vaccinia Ankara: progress in tumor-associated antigen-based immunotherapyRobert J Amato
Expert Review of Vaccines|September 5, 2008
Vaccine therapy for renal cancerRobert J Amato
Clinical Genitourinary Cancer|May 30, 2006
A phase I study of paclitaxel/doxorubicin/ thalidomide in patients with androgen- independent prostate cancerRobert J Amato, Harmeet Sarao
Pageof 7